The diseases reimbursed by Ji mainly include malignant tumors such as breast cancer, lung cancer, leukemia, liver cancer, lymphoma and melanoma, hepatitis, heart disease and cerebrovascular diseases, as well as spinal muscular atrophy, mucopolysaccharidosis type I, mucopolysaccharidosis type II, mucopolysaccharidosis type IV A, homozygous familial hypercholesterolemia, adult wild-type or transgenic thyroxine protein powder degenerative cardiomyopathy, hereditary angioedema and X-ray.